Description
ST3GAL4 gene expression is altered in different cancer types, including cervical cancer. Several mRNA transcripts have been reported for this gene. ST3GAL4 encodes for βgalactosidase α2,3sialyltransferase 4, involved in the biosynthesis of the tumour antigens sLe(x) and sulfosLe(x).
Specifications
|
Synonyms |
SIAT4; SIAT4C; ST3GAL4; ST3GalA.2; ST-4; STZSIAT4; CGS23; Gal-NAc 6S; NANTA3; SAT3; |
|
Uniprot No. |
Q11206.1 |
|
Source |
Recombinant Human ST3GAL4 Protein is expressed from HEK293 cells with His tag at the C-terminal and HA at the N-terminal. It contains Glu41-Phe333. |
|
Molecular Weight |
The protein has a predicted MW of 35.4 kDa. Due to glycosylation, the protein migrates to 48-53 kDa based on Tris-Bis PAGE result. |
|
Purity |
> 95% as determined by SDS-PAGE |
|
Endotoxin |
<1.0 EU per 1μg of the protein by the LAL method. |
|
Formulation |
Supplied as 0.22μm filtered solution in 20mM Tris, 500mM NaCl (pH 7.5). |
Storage
The product should be stored at -85~-65℃ for 1 year from the date of receipt.
Recommend to aliquot the protein into smaller quantities when first used and avoid repeated freeze-thaw cycles.
Note
1.Please operate with lab coats and disposable gloves for your safety.
2.This product is for research use only.
Product Data
Payment & Security
Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.
Inquiry
You may also like
FAQ
The product is for research purposes only and is not intended for therapeutic or diagnostic use in humans or animals. Products and content are protected by patents, trademarks, and copyrights owned by Yeasen Biotechnology. Trademark symbols indicate the country of origin, not necessarily registration in all regions.
Certain applications may require additional third-party intellectual property rights.
Yeasen is dedicated to ethical science, believing our research should address critical questions while ensuring safety and ethical standards.